These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 16163217)
1. Metronomic chemotherapy: teaching old drugs new tricks? Vogelzang N Clin Adv Hematol Oncol; 2004 Jul; 2(7):432-3. PubMed ID: 16163217 [No Abstract] [Full Text] [Related]
2. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352 [TBL] [Abstract][Full Text] [Related]
3. Metronomic chemotherapy: Back to the future! André N; Padovani L; Verschuur A Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080 [TBL] [Abstract][Full Text] [Related]
4. Can a rational design for metronomic chemotherapy dosing be devised? Maraveyas A; Lam T; Hetherington JW; Greenman J Br J Cancer; 2005 Apr; 92(8):1588-90. PubMed ID: 15846302 [No Abstract] [Full Text] [Related]
6. Microtubule-targeting agents in angiogenesis: where do we stand? Pasquier E; Honoré S; Braguer D Drug Resist Updat; 2006; 9(1-2):74-86. PubMed ID: 16714139 [TBL] [Abstract][Full Text] [Related]
7. [A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy]. Qiu H; Wang GM Ai Zheng; 2007 Dec; 26(12):1392-6. PubMed ID: 18076810 [TBL] [Abstract][Full Text] [Related]
8. Angiogenesis inhibitors. New anticancer strategy. Zgodziński W; Wallner G; Dabrowski A Pol J Pharmacol; 1999; 51(6):455-62. PubMed ID: 10817522 [TBL] [Abstract][Full Text] [Related]
9. Dynamical model for assessment of anti-angiogenic therapy of cancer. Mukherjee A; Majumder D Mol Biosyst; 2010 Jun; 6(6):1047-55. PubMed ID: 20358121 [TBL] [Abstract][Full Text] [Related]
10. On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A. Albertsson P; Lennernäs B; Norrby K Acta Oncol; 2006; 45(2):144-55. PubMed ID: 16546859 [TBL] [Abstract][Full Text] [Related]
11. Antiinvasive, antiangiogenic and antitumour activity of Ephedra sinica extract. Nam NH; Lee CW; Hong DH; Kim HM; Bae KH; Ahn BZ Phytother Res; 2003 Jan; 17(1):70-6. PubMed ID: 12557251 [TBL] [Abstract][Full Text] [Related]
12. [Metronomic chemotherapy in 2011: update and perspectives]. Benbrahim Z; Massard C; El Mesbahi O Bull Cancer; 2011 Dec; 98(12):1447-54. PubMed ID: 22146261 [TBL] [Abstract][Full Text] [Related]
13. A new way to attack cancer. Stipp D Fortune; 2000 May; 141(11):164-6, 168, 172 passim. PubMed ID: 10947559 [No Abstract] [Full Text] [Related]
16. Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells. Bertolini F Cancer Metastasis Rev; 2008 Mar; 27(1):95-101. PubMed ID: 18066648 [TBL] [Abstract][Full Text] [Related]
17. Cancer research. Obstacle for promising cancer therapy. Marx J Science; 2002 Feb; 295(5559):1444. PubMed ID: 11859164 [No Abstract] [Full Text] [Related]
18. Antitumor interaction of short course endostatin and ionizing radiation. Greenberger JS Cancer J; 2000; 6(5):279-81. PubMed ID: 11079164 [No Abstract] [Full Text] [Related]
19. Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy. Munoz R; Shaked Y; Bertolini F; Emmenegger U; Man S; Kerbel RS Breast; 2005 Dec; 14(6):466-79. PubMed ID: 16199161 [TBL] [Abstract][Full Text] [Related]